Our Blog

Recce Pharmaceuticals (ASX:RCE) targeting antibiotic resistant bacteria

30 Nov 2018 – Recce Pharmaceuticals Limited (ASX:RCE) Executive Director, James Graham provides an update on the company’s RECCE 327 product for use in targeting antibiotic resistant bacteria and its clinical pathway.


Source: Finance News Network

Share this post